The Indianapolis Colts are targeting a blocking tight end and a safety in the 2026 NFL Draft, with general manager Chris ...

Whether your team is a Stanley Cup contender and entering the NHL trading season as a buyer or a rebuilding club looking to ...

Stardew Valley's upcoming 1.7 update will include, among other things, two brand new marriage candidates, IGN can exclusively reveal. This comes from our interview with the game's creator, Eric Barone ...

Texas is setting up to have a high-powered rushing attack in 2026, as top transfer portal running back Raleek Brown is reportedly sticking to his commitment to the Longhorns even after Texas added ...

BATON ROUGE – LSU Beach Volleyball coach Russell Brock has announced the addition of two transfers – Emily Hellmuth and Zayna Meyer – who will join the Tigers for the upcoming season. Hellmuth and ...

Vertex could have several catalysts in 2026, helping it set a strong foundation for the future. DexCom is expanding its addressable market in order to help deal with some current challenges. Broader ...

ETFs offer a convenient way for investors to gain broad, diversified exposure to stocks. It's hard to beat Vanguard's S&P 500 ETF, which has delivered excellent results over time. Vanguard's ...

(RTTNews) - Q32 Bio Inc. (QTTB) has sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics, Inc. (AKBA), securing upfront and milestone payments that will extend its cash runway into the ...

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...

Omeros Corporation has surged after out-licensing zaltenibart to Novo Nordisk, securing $340 million upfront and near-term milestones, with potential for $2.1 billion in additional payments. The deal ...